Nexgel (NXGLW) EBIAT (2018 - 2025)
Nexgel's EBIAT history spans 8 years, with the latest figure at -$970000.0 for Q4 2025.
- For Q4 2025, EBIAT fell 17.72% year-over-year to -$970000.0; the TTM value through Dec 2025 reached -$2.9 million, up 13.53%, while the annual FY2025 figure was -$3.0 million, 13.37% up from the prior year.
- EBIAT reached -$970000.0 in Q4 2025 per NXGLW's latest filing, down from -$653000.0 in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$550000.0 in Q3 2023 to a low of -$1.8 million in Q1 2022.
- Average EBIAT over 5 years is -$924750.0, with a median of -$824500.0 recorded in 2021.
- The largest YoY upside for EBIAT was 60.46% in 2022 against a maximum downside of 160.8% in 2022.
- A 5-year view of EBIAT shows it stood at -$1.6 million in 2021, then surged by 60.46% to -$648000.0 in 2022, then plummeted by 69.44% to -$1.1 million in 2023, then rose by 24.95% to -$824000.0 in 2024, then decreased by 17.72% to -$970000.0 in 2025.
- Per Business Quant, the three most recent readings for NXGLW's EBIAT are -$970000.0 (Q4 2025), -$653000.0 (Q3 2025), and -$640000.0 (Q2 2025).